239 reports of this reaction
2.1% of all OZANIMOD HYDROCHLORIDE reports
#10 most reported adverse reaction
PAIN is the #10 most commonly reported adverse reaction for OZANIMOD HYDROCHLORIDE, manufactured by Celgene Corporation. There are 239 FDA adverse event reports linking OZANIMOD HYDROCHLORIDE to PAIN. This represents approximately 2.1% of all 11,558 adverse event reports for this drug.
Patients taking OZANIMOD HYDROCHLORIDE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for OZANIMOD HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for OZANIMOD HYDROCHLORIDE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 239 FDA reports for OZANIMOD HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.1% of all adverse event reports for OZANIMOD HYDROCHLORIDE, making it a notable side effect.
If you experience pain while taking OZANIMOD HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.